NRC Health Federal Income Tax Expense (Benefit), Continuing Operations
NRC Health (NRC) reported Federal Income Tax Expense (Benefit), Continuing Operations of $6.10 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2025-03-17
- NRC Health federal income tax expense (benefit), continuing operations for fiscal 2024 was $6.10M, a 16.77% decline from fiscal 2023.
- NRC Health federal income tax expense (benefit), continuing operations for fiscal 2023 was $7.33M, a 14.39% decline from fiscal 2022.
- NRC Health federal income tax expense (benefit), continuing operations for fiscal 2022 was $8.56M, a 3.46% decline from fiscal 2021.
- NRC Health federal income tax expense (benefit), continuing operations for fiscal 2021 was $8.87M, a 173.87% increase from fiscal 2020.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2024-12-31 | $6.10M 10-K · filed 2025-03-17 |
| 2023-12-31 | $7.33M 10-K · filed 2025-03-17 |
| 2022-12-31 | $8.56M 10-K · filed 2025-03-17 |
| 2021-12-31 | $8.87M 10-K · filed 2024-02-27 |
| 2020-12-31 | $3.24M 10-K · filed 2023-03-03 |
| 2019-12-31 | $6.29M 10-K · filed 2022-03-04 |
| 2018-12-31 | $3.47M 10-K · filed 2021-03-05 |
| 2017-12-31 | $9.35M 10-K · filed 2020-03-06 |
| 2016-12-31 | $9.78M 10-K · filed 2019-03-08 |
| 2015-12-31 | $8.72M 10-K · filed 2018-03-14 |
| 2014-12-31 | $8.68M 10-K · filed 2017-03-03 |
| 2013-12-31 | $7.36M 10-K · filed 2016-03-04 |
| 2012-12-31 | $6.63M 10-K · filed 2015-03-04 |
| 2011-12-31 | $5.19M 10-K · filed 2014-03-04 |
| 2010-12-31 | $3.91M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |